PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ION EXCHANGE RESINS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 955 records · Page 53Linked to original sources

[Application of adsorption resin separation technique in traditional China medicine research].

Adsorption resin separation is one of the new technologies developed after ion exchange resin in the 60's of the 20th century. It was early used in the fields of the wastewater treatment, pharmaceutical industry, chemical engineering, analytical chemistry, clinical detection and treatment. In recent years, the technique of adsorption resin separation has been widely used in research on active constituent of traditional China medicine. The recent application was reviewed in this paper.

Adsorption↗

Bilirubin removal from an hepatic failure patient by resin hemoperfusion.

An hemoperfusion (HP) column, packed with beads of a macroreticular MR ion exchange resin which were made biocompatible by coating with a fine layer of cross-linked human albumin, was applied to the removal of bilirubin (BIL) from a jaundiced 69-year old man with hepatic failure. The column was found most suitable for BIL removal. However, the high volumetric mass transfer coefficient of the unconjugated (UC) BIL indicates that this column could best be used for BIL removal from babies suffering from unconjugated hyperbilirubinemia.

Acute Disease↗

In vivo hemoperfusion studies of bilirubin removal from jaundiced dogs.

Removal of bilirubin by hemoperfusion (HP) on a macroreticular ion-exchange resin is suggested as a novel clinical procedure for the treatment of jaundiced newborn babies. The efficiency and biocompatibility of the proposed macroreticular (MR) ion exchange column was tested in vivo with jaundiced dogs. An animal model with a choledocho-suprarenal vein shunting allowed to test the column capacity for the adsorption of conjugated and unconjugated bilirubin. A second animal model, based on infusing unconjugated bilirubin directly into the blood stream, enabled to test the column operation at desired unconjugated bilirubin concentrations. The results of the in vivo hemoperfusion tests are very encouraging and compare favorably with bilirubin removal from babies by exchange transfusion (ET). Operating a column containing 10 ml resin per kg body weight for 3 hours removed over 1.7 times the initial unconjugated bilirubin content. Furthermore, the animals seemed to be unaffected by the HP procedure; the changes due to hemoperfusion on blood chemistry, hematology and some hormone levels were practically insignificant.

Animals↗

Membrane-based hybrid processes for high water recovery and selective inorganic pollutant separation.

The removal of heavy metals (e.g. Pb(II), Cd(II), Cu(II), etc.) and oxyanions (e.g. nitrate, As(III, V), Cr(VI), etc.) is of immense interest for treatment of groundwater and other dilute aqueous systems. However, the presence of non-toxic components, such as hardness (Ca, Mg) and sulfate, can interfere with the separation of toxic species. For example, pressure-driven membrane processes, such as reverse osmosis (RO), have been limited for water treatment due to problems that these extraneous components cause with water recovery and ionic strength (osmotic pressure) of the retentate. In addition, nitrate rejection by RO is considerably lower than NaCl rejection, resulting in permeate concentrations that may be too high for groundwater recharging. Other separation systems that rely solely on sorption of toxic species (e.g. ion exchange resins) may not have sufficient selectivity for efficient use in the presence of competing ions. Hence, implementation of pressure-driven membrane separations and high capacity sorbents in hybrid processes shows much promise for remedying these difficulties. For example, selective separation of nitrate may be achieved by combining nanofiltration (NF) for sulfate removal, followed by RO or ion exchange for nitrate removal (see example 1). When small concentrations of toxic metals are present, the large retentate volumes of RO processes may be reduced by selective removal of toxic species with a high capacity sorbent, thus permitting disposal of a lower volume, non-toxic stream (see example 2). The use of microfiltration membrane-based sorbents containing multiple polymeric functional groups is a novel technique to achieve high metal sorption capacity under convective flow conditions. These sorbents are formed by the attachment of various polyamino acids (MW: 2500-10,000), such as polyaspartic acid (cation sorption), polyarginine (oxyanion sorption), and polycysteine (chelation exchange), directly on the membrane pore surfaces. Since these sorbents have also been found to have high selectivity over non-toxic metals, such as calcium, they are ideal candidates for hybrid processing with RO/NF.

Adsorption↗

Activity enhancement by the support in the hydrogenation of C=C bonds over polymer-supported palladium catalysts

Four synthetic ion-exchange resins (AH, BH, CH, DH) of different hydrophilic/hydrophobic properties were used as supports for heterogeneous palladium catalysts (A, B, C, D). The resins contained styrene (STY) and 2-(methacryloxy)ethylsulfonic acid (MESA) as the comonomers. Either divinylbenzene (DVB: CH, DH resins) or N,N'-methylenebisacrylamide (MBAA: AH, BH resins) were used as the cross-linker. AH contained also N,N-dimethylacrylamide (DMAA) as the third comonomer. The catalysts (Pd 0.25-0.45% w/w) were obtained by ion-exchanging the acidic forms of the resins with [Pd(OAc)2] and reducing palladium(II) with excess sodium borohydride. The use of NaBH4 also ensured the neutralization of the acidic sites of the supports. No effect of the hydrophilic/hydrophobic properties of the supports was observed in the hydrogenation of cyclohexene and 2-cyclohexen-1-one in methanol, at 25 degrees C and 0.5, 1, and 1.5 MPa, respectively. However, catalysts A and B, containing amido groups provided by either DMAA or MBAA, proved to be more active than C and D. The observed activity enhancement was directly proportional to the nitrogen/ palladium molar ratio in the catalysts. This finding suggests that amido groups promote palladium through a direct interaction with the metal surface.

Journal Article↗

Utilization of cholestyramine resin as a preventive treatment for antibiotic (clindamycin) induced enterotoxaemia in the rabbit.

Cholestyramine, an ion exchange resin shown to bind bacterial toxins, was utilized to treat rabbits with antibiotic induced enterotoxaemia. Three groups of 6 rabbits were administered 30 mg/kg clindamycin phosphate intravenously on day 1. One group was untreated; 2 groups were treated daily by gavage with 2 g cholestyramine in 20 ml water until day 21, starting on either day 1 or 3. Daily body weights, faecal output, faecal occult blood, food and water consumption, and body temperatures were determined. Four of 6 rabbits in the untreated group either died or were moribund and euthanased. There were no deaths in either treatment groups. Dramatic decreases in food consumption (86%), water consumption (62%), and faecal output (89%) were noted within 3 days after clindamycin administration in all groups. These parameters remained depressed throughout the study. There was no clear trend in body weight changes, body temperature, or faecal occult blood test results. Cholestyramine was effective in eliminating mortality associated with the intravenous administration of clindamycin and is recommended to prevent the development of enterotoxaemia when pyrogen testing or administering antibiotics known to induce the syndrome in rabbits.

Animals↗

Creatine kinase isoenzyme MB determination on the ACA: dependence on serum matrix and other effectors.

Creatine kinase isoenzyme MB catalytic activities in human serum, determined by ACA ion exchange chromatography and immunoinhibition, differ significantly, the correlation coefficient being 0.88. The reasons for this variation are interference of antibodies with the creatine kinase B subunit in the immunoinhibition assay, nonreproducible elution of creatine kinase isoenzyme MB from the ion exchange resin in the ACA pack, due to varying protein concentrations in the serum samples and increasing elution of creatine kinase isoenzyme MM from the ion exchange column caused by a preceding partial inactivation of creatine kinase isoenzyme MM. Pretreatment of serum samples with a solution containing magnesium sulphate, maleate and 2-oxoglutarate (solution A) prior to determination of creatine kinase isoenzyme MB catalytic activities on the ACA significantly improves the sensitivity and specificity of the method; the correlation coefficient for the values from the ACA and immunoinhibition then becomes 0.92. Dilution of serum samples with bovine serum albumin solution is now practicable.

Aspartate Aminotransferases↗

Radioimmunoassay of arginine vasopressin in human plasma and urine, a resin microcolumn method.

A new method was developed for the estimation of arginine vasopressin (AVP) in plasma and urine. Samples were extracted by a microcolumn of resin and assayed radioimmunologically using a highly sensitive antiserum to AVP. Ion-exchange resin, CG-50, H+ form, packed in a small column (diameter 4 mm, height 6 mm), was proved effective to remove the interfering substances and to concentrate the AVP in the sample. The application of 80% acid acetone successive to diluted HCl brought about a consistent recovery of AVP from the resin column. Recoveries were 66.4 +/- 8.5% for plasma and 85.4 +/- 9.7% for urine. In normal subjects plasma AVP levels were 3.9 +/ 0.3 pg/ml (mean +/- S.D.) in ambulatory states, 4.9 +/- ).6 after overnight fast, and 0.4 +/- 0.2 after water lading. High levels of 2.0 +/- 24.2 pg/ml were obtained in patinents with syndrome of inappropriate secretion of ADH (SIADH), low values of 0-1.8 pg/ml in diabetes inipidus. Urinary excretions of AVP were 117.4 +/- 59.4 ng/24/hr (mean +/- S.D.) in normal controls, 191 +/- 177.0/24 hr in SIADH, and 17.0 +/- 12.0/24 hr in diabetes insipidus.

Arginine Vasopressin↗

A semi-continuous method for purification of factor IX complex from human plasma.

We report the development of a semi-continuous method for preparation of factor IX complex from human plasma using ion exchange resins. Traditionally, stirred batch adsorption has been used due to the high pressure drops and low flow rates associated with soft gels in packed columns. Batch methods, however, typically involve higher labor costs and are more cumbersome in process environments. In the semi-continuous process, cryo-supernatant plasma is pumped through a 'stirred column' containing the resin. At both lab and pilot scale, higher recoveries of factor IX (FIX) were obtained at decreased total process times, compared to batch adsorption. A residence time of 15 min was found to be sufficient for capture of 95% of the FIX in the starting plasma. In the pilot plant, 550 liters of plasma was passed through a 50-liter column containing 8.5 liters of resin, yielding a 68% recovery of FIX. The results suggest that the recovery of FIX depends on the mode of contact (batch, continuous or packed column) between plasma and resin.

Blood Coagulation Factors↗